In partnership with Ionis Pharmaceuticals, this program provides no-cost genetic testing for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by motor neuron impairment in the cortex, brain stem, and spinal cord. No-cost ALS testing is available for patients with a clinical diagnosis or family history of ALS. This program is currently being offered to residents of the U.S. and Canada who meet testing eligibility criteria.The test must be ordered by a qualified healthcare provider.
Sponsored by Biogen and offered through Invitae, a genetic testing provider, ALS Identified is a no-charge genetic testing program for amyotrophic lateral sclerosis (ALS). The program will test for mutations in more than 20 genes that are linked to ALS.
Decode Duchenne provides diagnostic testing for Duchenne and Becker muscular dystrophy. Decode Duchenne is a Collaborative partnership between Parent Project Muscular Dystrophy (PPMD), Sarepta Therapeutics and other industry partners, and Revvity Omics.
Since 2013, PPMD has been proud to offer free genetic testing, counseling support, and education through Decode Duchenne. Decode Duchenne offers free genetic testing to people in the Becker and Duchenne muscular dystrophy community who otherwise would be unable to access genetic testing. For asymptomatic carrier testing, please visit PPMD’s website and submit an application.
You can also access free genetic counseling support for Duchenne and Becker muscular dystrophy at PPMD at 888-520-8675 (option 1) or emailing [email protected].
For Health Care Professionals already familiar with Duchenne and Becker muscular dystrophy, feel free to use the links below to order a kit or submit a sample.
Genetic testing may bring you closer to understanding what’s causing your patient’s epilepsy, helping your patients and their caregivers benefit from deeper knowledge and timely care.
